MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GLUE has $448,659K in assets. $215,603K in debts. $129,883K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
612.32%
Quick Ratio
612.32%
Cash Ratio
202.27%
Debt to Asset Ratio
48.05%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, net of current
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
129,883
Marketable securities
247,221
Collaboration receivable
7,000
Other receivables
4,600
Prepaid expenses and other current assets
4,481
Total current assets
393,185
Total property and equipment, at cost
53,599
Less accumulated depreciation
27,613
Property and equipment, net
25,986
Operating lease right-of-use assets
24,386
Restricted cash
4,954
Other long-term assets
148
Total assets
448,659
Accounts payable
3,550
Accrued expenses and other current liabilities
26,694
Current deferred revenue
29,571
Current portion of operating lease liability
4,397
Total current liabilities
64,212
Deferred revenue, net of current
111,332
Defined benefit plan liability
5,265
Operating lease liability, net of current
34,794
Total liabilities
215,603
Common stock, 0.0001 par value 500,000,000 shares authorized, 61,790,239 and 61,507,446 shares issued and outstanding as of december 31, 2025 and 2024, respectively
7
Additional paid-in capital
714,090
Accumulated other comprehensive loss
-3,827
Accumulated deficit
-477,214
Total stockholders' equity
233,056
Total liabilities and stockholders' equity
448,659
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$247,221K Cash and cashequivalents$129,883K Collaboration receivable$7,000K Other receivables$4,600K Prepaid expenses andother current assets$4,481K Total property andequipment, at cost$53,599K Total current assets$393,185K Property and equipment,net$25,986K Operating leaseright-of-use assets$24,386K Restricted cash$4,954K Other long-termassets$148K Less accumulateddepreciation$27,613K Total assets$448,659K Total liabilities andstockholders' equity$448,659K Total stockholders'equity$233,056K Total liabilities$215,603K Accumulated deficit-$477,214K Accumulated othercomprehensive loss-$3,827K Additional paid-in capital$714,090K Deferred revenue, net ofcurrent$111,332K Total currentliabilities$64,212K Operating leaseliability, net of current$34,794K Defined benefit planliability$5,265K Common stock, 0.0001par value...$7K Current deferredrevenue$29,571K Accrued expenses andother current...$26,694K Current portion ofoperating lease liability$4,397K Accounts payable$3,550K

Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE)